# Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC

> **NCT07738367** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **Fujian Cancer Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer(NSCLC)

## Interventions

- **PROCEDURE:** Bronchial Arterial Chemoembolization (BACE)
- **DRUG:** Systemic anti-tumor combination medications

## Key facts

- **NCT ID:** NCT07738367
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-04-09
- **Primary completion:** 2028-04-30
- **Final completion:** 2028-10-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07738367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07738367, "Bronchial Artery Chemoembolization (BACE) Combination Therapy for Advanced NSCLC". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07738367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*